{"componentChunkName":"component---src-templates-blog-post-js","path":"/analysis-updates/how-probable-cases-changed-through-the-covid-19-pandemic","result":{"data":{"contentfulBlogPost":{"contentful_id":"1Q5lsJ7i5vsM3RptAQXY36","title":"How Probable Cases Changed Through the COVID-19 Pandemic","updateDateTime":null,"twitterText":null,"authors":[{"name":"Madhavi Bharadwaj","twitterLink":"https://twitter.com/madhavibharad","twitterHandle":"madhavibharad","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Madhavi Bharadwaj is a data driven creative thinker and lifelong learner who is passionate about healthcare and public health.</p>"}},"headshot":{"file":{"fileName":"IMG_1421 (1).jpg"},"resize":{"width":200,"height":195,"src":"//images.ctfassets.net/o2ll9t4ee8tq/32GrQSzXJSxiIpXeq8B4LD/fc26e02bc58d26a9ce77076f71d6b163/IMG_1421__1_.jpg?w=200&fl=progressive&q=50"}}},{"name":"Lauran Hazan","twitterLink":"https://twitter.com/icanhazan","twitterHandle":"icanhazan","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Lauran Hazan is a product management leader with a minor data obsession. Currently in the Boston area on a new startup adventure.</p>"}},"headshot":{"file":{"fileName":"LH.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/5wohmJKHgxRbOGOTAa6tBg/1dcf2b70af7c18966eedd0339cecf4b1/LH.png?w=200&fl=progressive&q=50"}}},{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}},{"name":"Sara Simon","twitterLink":"https://twitter.com/sarambsimon","twitterHandle":"sarambsimon","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Sara Simon works on The COVID Tracking Project’s data quality team and is also a contributing writer. She most recently worked as an investigative data reporter at Spotlight PA and software engineer at The New York Times.</p>"}},"headshot":{"file":{"fileName":"sara-simon-headshot.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1SyhStbwHt8Buu5isH509w/cec8275f95bde3e4c23fbe55fcccc432/sara-simon-headshot.jpg?w=200&fl=progressive&q=50"}}}],"socialCard":{"description":{"description":"When analyzing COVID-19 data, confirmed case counts are obvious to study. But don’t overlook probable cases—and the varying, evolving ways that states have defined them.\n"},"image":{"resize":{"src":"//images.ctfassets.net/o2ll9t4ee8tq/73DzIHFH2o3rKOXGMSYvlp/1d25efe9004cca7c195d2c4e149d8d0d/image6.png?w=1200&fl=progressive&q=50"}}},"relatedBlogPosts":null,"childContentfulBlogPostFootnotesTextNode":{"childMarkdownRemark":{"html":"<p><em>On June 3, 2021, we updated language to reflect our confirmation of Vermont’s custom probable case definition with the state health department. We had been unable to reach them to confirm before publication.</em></p>"}},"categories":[{"name":"Testing Data","slug":"testing-data","blog_post":[{"slug":"how-probable-cases-changed-through-the-covid-19-pandemic","publishDate":"May 20, 2021","authors":[{"name":"Madhavi Bharadwaj","twitterLink":"https://twitter.com/madhavibharad","twitterHandle":"madhavibharad","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Madhavi Bharadwaj is a data driven creative thinker and lifelong learner who is passionate about healthcare and public health.</p>"}},"headshot":{"file":{"fileName":"IMG_1421 (1).jpg"},"resize":{"width":200,"height":195,"src":"//images.ctfassets.net/o2ll9t4ee8tq/32GrQSzXJSxiIpXeq8B4LD/fc26e02bc58d26a9ce77076f71d6b163/IMG_1421__1_.jpg?w=200&fl=progressive&q=50"}}},{"name":"Lauran Hazan","twitterLink":"https://twitter.com/icanhazan","twitterHandle":"icanhazan","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Lauran Hazan is a product management leader with a minor data obsession. Currently in the Boston area on a new startup adventure.</p>"}},"headshot":{"file":{"fileName":"LH.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/5wohmJKHgxRbOGOTAa6tBg/1dcf2b70af7c18966eedd0339cecf4b1/LH.png?w=200&fl=progressive&q=50"}}},{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}},{"name":"Sara Simon","twitterLink":"https://twitter.com/sarambsimon","twitterHandle":"sarambsimon","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Sara Simon works on The COVID Tracking Project’s data quality team and is also a contributing writer. She most recently worked as an investigative data reporter at Spotlight PA and software engineer at The New York Times.</p>"}},"headshot":{"file":{"fileName":"sara-simon-headshot.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1SyhStbwHt8Buu5isH509w/cec8275f95bde3e4c23fbe55fcccc432/sara-simon-headshot.jpg?w=200&fl=progressive&q=50"}}}],"title":"How Probable Cases Changed Through the COVID-19 Pandemic","lede":{"lede":"When analyzing COVID-19 data, confirmed case counts are obvious to study. But don’t overlook probable cases—and the varying, evolving ways that states have defined them.\n"}},{"slug":"why-we-didnt-automate-our-data-collection","publishDate":"May 28, 2021","authors":[{"name":"Jonathan Gilmour","twitterLink":null,"twitterHandle":null,"link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jonathan Gilmour is a Data Infrastructure engineer and Data Quality contributor at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"IMG_2198.jpg"},"resize":{"width":200,"height":199,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3czVgHQ6fsml4UEePyyOcA/5963a9b5d839552cde3e382c12de2334/IMG_2198.jpg?w=200&fl=progressive&q=50"}}}],"title":"20,000 Hours of Data Entry: Why We Didn’t Automate Our Data Collection","lede":{"lede":"Looking back on a year of collecting COVID-19 data, here’s a summary of the tools we automated to make our data entry smoother and why we ultimately relied on manual data collection.\n"}},{"slug":"five-major-metrics-covid-19-data","publishDate":"May 24, 2021","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}},{"name":"Sara Simon","twitterLink":"https://twitter.com/sarambsimon","twitterHandle":"sarambsimon","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Sara Simon works on The COVID Tracking Project’s data quality team and is also a contributing writer. She most recently worked as an investigative data reporter at Spotlight PA and software engineer at The New York Times.</p>"}},"headshot":{"file":{"fileName":"sara-simon-headshot.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1SyhStbwHt8Buu5isH509w/cec8275f95bde3e4c23fbe55fcccc432/sara-simon-headshot.jpg?w=200&fl=progressive&q=50"}}}],"title":"A Wrap-Up: The Five Major Metrics of COVID-19 Data","lede":{"lede":"As The COVID Tracking Project comes to a close, here’s a summary of how states reported data on the five major COVID-19 metrics we tracked—tests, cases, deaths, hospitalizations, and recoveries—and how reporting complexities shaped the data."}},{"slug":"releasing-our-state-covid-19-data-log","publishDate":"April 28, 2021","authors":[{"name":"The COVID Tracking Project","twitterLink":"https://twitter.com/COVID19Tracking","twitterHandle":"COVID19Tracking","link":"https://covidtracking.com/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>The COVID Tracking Project is a volunteer organization launched from The Atlantic and dedicated to collecting and publishing the data required to understand the COVID-19 outbreak in the United States.</p>"}},"headshot":{"file":{"fileName":"bJ4lH6YI_400x400.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/18x0Pew7buAVkivgzsW5Qy/3e5142ca4d4ff8f31d79e232f6d369db/bJ4lH6YI_400x400.png?w=200&fl=progressive&q=50"}}}],"title":"Releasing Our State COVID-19 Data Log","lede":{"lede":"From July 2020 to March 2021, The COVID Tracking Project compiled a detailed set of structured COVID-19 data notes, both on changes states made to the data and changes we made to the data we captured from states. Today, we’re releasing those notes.\n"}},{"slug":"how-we-entered-covid-19-testing-outcomes-data","publishDate":"April 28, 2021","authors":[{"name":"Hannah Hoffman","twitterLink":null,"twitterHandle":null,"link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Hannah Hoffman is a data entry and data quality shift lead at The COVID Tracking Project and a student in the Washington, DC area.</p>"}},"headshot":{"file":{"fileName":"Image from iOS (1).jpg"},"resize":{"width":200,"height":250,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3dKAXYqEcRf9qijDkYS4wZ/8732b5f33b7023993ef222f3ed9c6e11/Image_from_iOS__1_.jpg?w=200&fl=progressive&q=50"}}}],"title":"How We Entered COVID-19 Testing and Outcomes Data Every Day for a Year","lede":{"lede":"We set up a set of roles and a shift system to carefully gather and inspect the data we published. \n"}},{"slug":"federal-covid-19-test-data-is-getting-better","publishDate":"April 21, 2021","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}}],"title":"Federal COVID-19 Testing Data Is Getting Better","lede":{"lede":"The federal government improved its state and county-level COVID-19 PCR testing data since we analyzed it in February. Here’s an update on those changes and what we hope to see next for the data."}},{"slug":"three-covid-19-data-problems","publishDate":"April 8, 2021","authors":[{"name":"Sara Simon","twitterLink":"https://twitter.com/sarambsimon","twitterHandle":"sarambsimon","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Sara Simon works on The COVID Tracking Project’s data quality team and is also a contributing writer. She most recently worked as an investigative data reporter at Spotlight PA and software engineer at The New York Times.</p>"}},"headshot":{"file":{"fileName":"sara-simon-headshot.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1SyhStbwHt8Buu5isH509w/cec8275f95bde3e4c23fbe55fcccc432/sara-simon-headshot.jpg?w=200&fl=progressive&q=50"}}}],"title":"Inconsistent Reporting Practices Hampered Our Ability to Analyze COVID-19 Data. Here Are Three Common Problems We Identified.","lede":{"lede":"With little consistency in how states defined, published, and presented COVID-19 data, it is difficult to compare situations across states.\n"}},{"slug":"new-surge-michigan","publishDate":"March 18, 2021","authors":[{"name":"Conor Kelly","twitterLink":"https://twitter.com/CohoKelly","twitterHandle":"CohoKelly","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Conor Kelly is the director of data analytics at Hanover Research.</p>"}},"headshot":{"file":{"fileName":"0.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/69bo9CT4zaWlhgPWsbryGC/9125242dc83bec36e78214580f96b97d/0.jpg?w=200&fl=progressive&q=50"}}},{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Dave Luo","twitterLink":"https://twitter.com/anthropoco","twitterHandle":"anthropoco","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Dave Luo has an MD/MBA and is a Data Science and Data Viz lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"daveluo_profilepic_greatbasin.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2JHQ4wsKT4XgJ1PZDXXru3/4097967dc949dddb7b4b4ef4c219f3f8/daveluo_profilepic_greatbasin.jpg?w=200&fl=progressive&q=50"}}},{"name":"Alexis Madrigal","twitterLink":"https://twitter.com/alexismadrigal","twitterHandle":"alexismadrigal","link":"https://www.theatlantic.com/author/alexis-madrigal","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Alexis C. Madrigal is a staff writer at The Atlantic, a co-founder of the COVID Tracking Project, and the author of <em>Powering the Dream: The History and Promise of Green Technology</em>.</p>"}},"headshot":{"file":{"fileName":"original.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3vW1aeLjPFSMAZOqHv9TQS/b4ffb03526cf67724c6732c6e11a6cef/original.png?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"A New Surge Has Arrived in Michigan, but We Don’t Know What It Will Look Like","lede":{"lede":"According to federal data, COVID-19 cases and hospitalizations have reversed their decline in Michigan, marking a new surge concentrated in and around Detroit, but affecting regions statewide. "}},{"slug":"releasing-our-annotations-on-covid-19-state-data-definitions","publishDate":"March 5, 2021","authors":[{"name":"The COVID Tracking Project","twitterLink":"https://twitter.com/COVID19Tracking","twitterHandle":"COVID19Tracking","link":"https://covidtracking.com/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>The COVID Tracking Project is a volunteer organization launched from The Atlantic and dedicated to collecting and publishing the data required to understand the COVID-19 outbreak in the United States.</p>"}},"headshot":{"file":{"fileName":"bJ4lH6YI_400x400.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/18x0Pew7buAVkivgzsW5Qy/3e5142ca4d4ff8f31d79e232f6d369db/bJ4lH6YI_400x400.png?w=200&fl=progressive&q=50"}}}],"title":"Releasing our Annotations on COVID-19 State Data Definitions","lede":{"lede":"As part of our wind-down process, we’re publicly sharing our structured metadata on state COVID-19 data definitions."}},{"slug":"simple-covid-data","publishDate":"March 4, 2021","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}}],"title":"Where to Find Simple COVID-19 Data for the US","lede":{"lede":"As The COVID Tracking Project approaches its final day of data compilation on March 7, 2021, we are recommending a selection of federal data sources to people who want a quick and easy way to keep an eye on the pandemic."}},{"slug":"giving-thanks-and-looking-ahead-our-data-collection-work-is-done","publishDate":"March 8, 2021","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Alexis Madrigal","twitterLink":"https://twitter.com/alexismadrigal","twitterHandle":"alexismadrigal","link":"https://www.theatlantic.com/author/alexis-madrigal","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Alexis C. Madrigal is a staff writer at The Atlantic, a co-founder of the COVID Tracking Project, and the author of <em>Powering the Dream: The History and Promise of Green Technology</em>.</p>"}},"headshot":{"file":{"fileName":"original.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3vW1aeLjPFSMAZOqHv9TQS/b4ffb03526cf67724c6732c6e11a6cef/original.png?w=200&fl=progressive&q=50"}}}],"title":"Giving Thanks and Looking Ahead: Our Data Collection Work Is Done","lede":{"lede":"While our work to compile COVID-19 data has concluded, we will continue to share research, analysis, and documentation in the months ahead. We are enormously grateful to the hundreds of volunteers who made this work possible."}},{"slug":"federal-covid-data-101-working-with-testing-data","publishDate":"March 5, 2021","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}}],"title":"Federal COVID Data 101: Working with Testing Data","lede":{"lede":"At least three different federal agencies share testing data for SARS-CoV-2 in at least four different places. Here’s a little about where that data comes from, what each dataset has to offer, and how you can use the datasets best in light of their large differences from state-provided data.\n"}},{"slug":"how-day-of-week-effects-impact-covid-19-data","publishDate":"February 22, 2021","authors":[{"name":"Hannah Hoffman","twitterLink":null,"twitterHandle":null,"link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Hannah Hoffman is a data entry and data quality shift lead at The COVID Tracking Project and a student in the Washington, DC area.</p>"}},"headshot":{"file":{"fileName":"Image from iOS (1).jpg"},"resize":{"width":200,"height":250,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3dKAXYqEcRf9qijDkYS4wZ/8732b5f33b7023993ef222f3ed9c6e11/Image_from_iOS__1_.jpg?w=200&fl=progressive&q=50"}}}],"title":"How Day-of-Week Effects Impact COVID-19 Data","lede":{"lede":"An understanding of state reporting schedules and day-of-week effects can help explain the reasons that numbers fluctuate from day to day, and what those changes mean.   "}},{"slug":"federal-testing-datas-last-mile","publishDate":"February 17, 2021","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}}],"title":"Federal Testing Data’s Last Mile","lede":{"lede":"Federal testing data is already more standardized and more detailed than the data we compile from states can ever be. But in some jurisdictions, state-provided data still provides a more comprehensive picture of testing volume. The federal government should address lingering quality problems so its data can become the national standard. \n"}},{"slug":"silent-data-mismatches-are-compromising-key-covid-19-indicators","publishDate":"February 9, 2021","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}},{"name":"Sara Simon","twitterLink":"https://twitter.com/sarambsimon","twitterHandle":"sarambsimon","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Sara Simon works on The COVID Tracking Project’s data quality team and is also a contributing writer. She most recently worked as an investigative data reporter at Spotlight PA and software engineer at The New York Times.</p>"}},"headshot":{"file":{"fileName":"sara-simon-headshot.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1SyhStbwHt8Buu5isH509w/cec8275f95bde3e4c23fbe55fcccc432/sara-simon-headshot.jpg?w=200&fl=progressive&q=50"}}}],"title":"Silent Data Mismatches Are Compromising Key COVID-19 Indicators ","lede":{"lede":"Although we’d prefer to have precise, real-time, comprehensive COVID-19 data for every US state and territory, the reality is that every metric that each jurisdiction publishes comes with quirks of timing and content that can make precise calculations impossible.\n"}},{"slug":"better-covid-19-data-is-coming","publishDate":"June 29, 2020","authors":[{"name":"Michael Parks","twitterLink":null,"twitterHandle":null,"link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Michael Parks is a journalist and communications specialist with a background in energy research and policy.</p>"}},"headshot":{"file":{"fileName":"michael-parks.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2Pv8DTatH3ZmKfXzKGDwYu/3927d57efe859adbe5dcfea1d2f7952d/michael-parks.jpg?w=200&fl=progressive&q=50"}}},{"name":"Nicole Rivera","twitterLink":null,"twitterHandle":null,"link":"https://www.linkedin.com/in/nicolerivera1","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Nicole Rivera is a policy and public affairs professional who has focused on developing creative and strategic ways to communicate complex issues with clarity.</p>"}},"headshot":{"file":{"fileName":"nicole-rivera.jpg"},"resize":{"width":200,"height":196,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2c8DoidCktjw1gD3TnTd4L/66b135e08da29a447e4fd418e176190c/nicole-rivera.jpg?w=200&fl=progressive&q=50"}}}],"title":"Better COVID-19 Data Is Coming By August 1—But Will the Public See It?","lede":{"lede":"Starting in August, new federal rules will require testing labs to report better data on the spread of COVID-19 in the United States. What happens to this new information is up to state and local officials. Journalists, open-data advocates, and members of the public can help us hold governments accountable for collecting and publishing this urgently needed data. "}},{"slug":"all-eyes-on-hospitalizations-dec-30","publishDate":"December 31, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"All Eyes on Hospitalizations: This Week in COVID-19 Data, Dec 30","lede":{"lede":"Holiday reporting has garbled most metrics. Going by current COVID-19 hospitalizations, outbreaks in the Midwest are still easing, but every other region is in trouble. "}},{"slug":"how-we-source-our-data","publishDate":"December 22, 2020","authors":[{"name":"Hannah Hoffman","twitterLink":null,"twitterHandle":null,"link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Hannah Hoffman is a data entry and data quality shift lead at The COVID Tracking Project and a student in the Washington, DC area.</p>"}},"headshot":{"file":{"fileName":"Image from iOS (1).jpg"},"resize":{"width":200,"height":250,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3dKAXYqEcRf9qijDkYS4wZ/8732b5f33b7023993ef222f3ed9c6e11/Image_from_iOS__1_.jpg?w=200&fl=progressive&q=50"}}}],"title":"How We Source Our Data and Why It Matters","lede":{"lede":"States provide COVID-19 data in a variety of sources and formats. To ensure our data is as accurate and consistent as possible, we spend a lot of time looking at these sources to make sure that we’re capturing the most data possible for each state, while maintaining high standards of data quality and integrity. Today, we’re publicly releasing a detailed set of notes on the sources of all our data points."}},{"slug":"counting-covid-19-tests","publishDate":"August 13, 2020","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}}],"title":"Counting COVID-19 Tests: How States Do It, How We Do It, and What’s Changing","lede":{"lede":"Many states have moved toward greater transparency about their test data reporting methods, and we’re making changes to better represent what they publish. We’re also introducing a “new” way some states are counting tests—one we think all states and territories would be wise to embrace."}},{"slug":"test-types-101","publishDate":"December 16, 2020","authors":[{"name":"Júlia Ledur","twitterLink":"https://twitter.com/juledurg","twitterHandle":"juledurg","link":"https://www.linkedin.com/in/j%C3%BAlia-ledur/en-us","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Júlia Ledur is a visual journalist and illustrator who leads the visualization team at The COVID Tracking Project. She is a former graphics reporter at Reuters. </p>"}},"headshot":{"file":{"fileName":"L6YFpyfj_400x400.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3Ti7VtyPTSUAi9RKRhu4sS/537660d90a09e2329d8a7ab9fbc657a6/L6YFpyfj_400x400.jpg?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}}],"title":"Test Types 101: The Pros and Cons of Different Approaches","lede":{"lede":"Once limited to molecular tests, the United States now has other testing methods available. Their efficacy depends on multiple factors, including how far the person tested is in their infection and how high the test positivity is where they live."}},{"slug":"cases-matter","publishDate":"October 27, 2020","authors":[{"name":"The COVID Tracking Project","twitterLink":"https://twitter.com/COVID19Tracking","twitterHandle":"COVID19Tracking","link":"https://covidtracking.com/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>The COVID Tracking Project is a volunteer organization launched from The Atlantic and dedicated to collecting and publishing the data required to understand the COVID-19 outbreak in the United States.</p>"}},"headshot":{"file":{"fileName":"bJ4lH6YI_400x400.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/18x0Pew7buAVkivgzsW5Qy/3e5142ca4d4ff8f31d79e232f6d369db/bJ4lH6YI_400x400.png?w=200&fl=progressive&q=50"}}}],"title":"Cases Matter","lede":{"lede":"As COVID-19 cases rise across the United States, claims are circulating that case increases are (mostly or entirely) due to expanded testing, and do not indicate a spike in infections. The data does not support this conclusion."}},{"slug":"good-news-about-floridas-testing-data","publishDate":"October 27, 2020","authors":[{"name":"Kara W. Schechtman","twitterLink":"http://twitter.com/karaschechtman","twitterHandle":"karaschechtman","link":"http://twitter.com/karaschechtman","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Kara Schechtman is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"image (13).png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2pZKoYrqpcylaBsGICO67t/a4f73160d2c940f34ce2f95a6173e2ab/image__13_.png?w=200&fl=progressive&q=50"}}},{"name":"Michal Mart","twitterLink":"https://twitter.com/COVID19Tracking","twitterHandle":"COVID19Tracking","link":"https://www.linkedin.com/in/michal-mart-992227107/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Michal Mart is Data Quality Co-Lead for The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"michal.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1HbCKbFs8oJwUWiZz7nPme/e0a88ff492707900507f0d0df4e0f8d2/michal.jpg?w=200&fl=progressive&q=50"}}}],"title":"Good News about Florida’s Testing Data","lede":{"lede":"Florida is now publishing a full time series of test encounters, so we are picking up this metric in our API and on our website. "}},{"slug":"daily-covid-19-data-is-about-to-get-weird","publishDate":"November 24, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}}],"title":"Daily COVID-19 Data Is About to Get Weird","lede":{"lede":"The upcoming holiday means that many COVID-19 metrics are going to drop—and then rise—in ways that may trip up unsuspecting observers. Here’s what to watch out for."}},{"slug":"what-we-know-about-covid-testing-sensitivity","publishDate":"November 23, 2020","authors":[{"name":"Whet Moser","twitterLink":"https://twitter.com/whet","twitterHandle":"whet","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Whet Moser is a freelance writer in Chicago.</p>"}},"headshot":{"file":{"fileName":"IMG_20190208_144139988.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1OryeSBI0s9kSAHpiLnJHj/be02c5a63ad3ebfa3bb852adf1cdf191/IMG_20190208_144139988.jpg?w=200&fl=progressive&q=50"}}}],"title":"What We Know About Covid Testing Sensitivity","lede":{"lede":"To successfully manage the pandemic, we need tools for both surveillance and diagnosis, in the form of antigen tests and PCR tests."}},{"slug":"national-dashboard-recommendations","publishDate":"November 11, 2020","authors":[{"name":"The COVID Tracking Project","twitterLink":"https://twitter.com/COVID19Tracking","twitterHandle":"COVID19Tracking","link":"https://covidtracking.com/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>The COVID Tracking Project is a volunteer organization launched from The Atlantic and dedicated to collecting and publishing the data required to understand the COVID-19 outbreak in the United States.</p>"}},"headshot":{"file":{"fileName":"bJ4lH6YI_400x400.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/18x0Pew7buAVkivgzsW5Qy/3e5142ca4d4ff8f31d79e232f6d369db/bJ4lH6YI_400x400.png?w=200&fl=progressive&q=50"}}}],"title":"Ultralight Recommendations for a National Pandemic Dashboard","lede":{"lede":"The announcement of a forthcoming national pandemic dashboard is heartening news for COVID-19 data folks all over the country. We have a few modest suggestions for the team that will undertake this work."}},{"slug":"the-other-covid-19-metric","publishDate":"June 29, 2020","authors":[{"name":"Tong Wang","twitterLink":"https://twitter.com/twang0518","twitterHandle":"twang0518","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Tong Wang is an MD-PhD candidate at the University of Pennsylvania. </p>"}},"headshot":{"file":{"fileName":"tong.jpeg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3pMFs5KIWqUt9TrlxWOPu3/21fc897c50e6e102ac82a33721442a19/tong.jpeg?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Júlia Ledur","twitterLink":"https://twitter.com/juledurg","twitterHandle":"juledurg","link":"https://www.linkedin.com/in/j%C3%BAlia-ledur/en-us","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Júlia Ledur is a visual journalist and illustrator who leads the visualization team at The COVID Tracking Project. She is a former graphics reporter at Reuters. </p>"}},"headshot":{"file":{"fileName":"L6YFpyfj_400x400.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3Ti7VtyPTSUAi9RKRhu4sS/537660d90a09e2329d8a7ab9fbc657a6/L6YFpyfj_400x400.jpg?w=200&fl=progressive&q=50"}}}],"title":"The Other COVID-19 Metric We Should Be Using","lede":{"lede":"As exposure risk increases, so does the need for more testing. The more we test, the more cases we can identify—which is a good thing. But are we looking at the right metrics to know if we are performing enough tests? "}},{"slug":"its-not-just-testing","publishDate":"June 24, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}}],"title":"It's Not Just Testing","lede":{"lede":"As case counts surge, we look at regional and state-level numbers to find out which recent jumps in COVID-19 case counts are likely to be explained by increased testing, and which are not. For the states with the worst recent numbers, the news is not good. "}},{"slug":"test-positivity-in-the-us-is-a-mess","publishDate":"October 8, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}}],"title":"Test Positivity in the US Is a Mess","lede":{"lede":"Interpreted correctly, test positivity can tell us so much that we need to know about COVID-19 outbreaks and testing in the United States. But we don’t publish test positivity calculations for US states and territories. Here’s why."}},{"slug":"antigen-testing-reporting","publishDate":"October 19, 2020","authors":[{"name":"Betsy Ladyzhets","twitterLink":"https://twitter.com/betsyladyzhets","twitterHandle":"betsyladyzhets","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Betsy Ladyzhets is a Research Editor at <a href=\"https://thestacker.com/\" title=\"Stacker\">Stacker</a> and works on data quality and the COVID Racial Data Tracker at the COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"LADYZHETS_HEADSHOT.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/76dnmWC2K5Ps2IWBe9oyF8/8dc13b77432989eb8596d61a8c1a7e93/LADYZHETS_HEADSHOT.jpg?w=200&fl=progressive&q=50"}}},{"name":"Quang P. Nguyen","twitterLink":"https://twitter.com/quangpmnguyen","twitterHandle":"quangpmnguyen","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Quang P. Nguyen is a PhD candidate in the Department of Epidemiology at Dartmouth College.</p>"}},"headshot":{"file":{"fileName":"Quang.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2XwoiQ3eBUJl7Fyeh4qi4Y/1f8e82642e28d279dbffa1d6a7c6af09/Quang.jpg?w=200&fl=progressive&q=50"}}}],"title":"The State of State Antigen Test Reporting","lede":{"lede":"Antigen tests are becoming a major tool for rapid COVID-19 testing. But if states don’t report results clearly, we won’t know the true impact of these tests."}},{"slug":"test-positivity","publishDate":"September 22, 2020","authors":[{"name":"Júlia Ledur","twitterLink":"https://twitter.com/juledurg","twitterHandle":"juledurg","link":"https://www.linkedin.com/in/j%C3%BAlia-ledur/en-us","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Júlia Ledur is a visual journalist and illustrator who leads the visualization team at The COVID Tracking Project. She is a former graphics reporter at Reuters. </p>"}},"headshot":{"file":{"fileName":"L6YFpyfj_400x400.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3Ti7VtyPTSUAi9RKRhu4sS/537660d90a09e2329d8a7ab9fbc657a6/L6YFpyfj_400x400.jpg?w=200&fl=progressive&q=50"}}},{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Tong Wang","twitterLink":"https://twitter.com/twang0518","twitterHandle":"twang0518","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Tong Wang is an MD-PhD candidate at the University of Pennsylvania. </p>"}},"headshot":{"file":{"fileName":"tong.jpeg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3pMFs5KIWqUt9TrlxWOPu3/21fc897c50e6e102ac82a33721442a19/tong.jpeg?w=200&fl=progressive&q=50"}}}],"title":"Test Positivity: So Valuable, So Easy to Misinterpret","lede":{"lede":"Test positivity is extremely useful, but it has also become one of the most commonly misunderstood metrics for monitoring the COVID-19 pandemic. Here, we take a step back and look at what it really means."}},{"slug":"testing-in-limbo-hospitalizations-deaths-still-dropping","publishDate":"September 10, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"Testing In Limbo, Hospitalizations and Deaths Still Dropping: This Week in COVID-19 Data, Sep 10","lede":{"lede":"A long holiday weekend makes ambiguous testing data even harder to understand, but hospitalizations are dropping, which is good."}},{"slug":"weekly-covid-19-update-holiday-reporting-lags-interrupt-positive-trends","publishDate":"September 17, 2020","authors":[{"name":"Joanna Pearlstein","twitterLink":"https://twitter.com/jopearl","twitterHandle":"jopearl","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Joanna Pearlstein is an editorial lead at the Covid Tracking Project and a former editor at WIRED and Protocol.</p>"}},"headshot":{"file":{"fileName":"joanna image 2.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2bDyWZYAzNBA1wwPdanQxj/6d05a2f2305f881a52910af4eab29223/joanna_image_2.png?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"Holiday Reporting Lags Interrupt Positive Trends: This Week in COVID-19 Data, Sep 17","lede":{"lede":"Though cases are rising in parts of the Midwest, hospitalizations in the West and South continued trending downward. The Labor Day holiday impacted data reporting lag times both this week and last, obscuring what had been positive trends in September."}},{"slug":"cases-stop-dropping-and-the-midwest-heats-up","publishDate":"September 3, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}},{"name":"Rebecca Glassman","twitterLink":"NotoriousRSG","twitterHandle":"NotoriousRSG","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Rebecca Glassman has a Master’s in Public Health and is a public health researcher in academia. Opinions expressed are her own.</p>"}},"headshot":{"file":{"fileName":"USWNT.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/5wMqOnESrEIVOIzkFy6drZ/7e21b52b5bc813ac4860ffada759fe46/USWNT.jpg?w=200&fl=progressive&q=50"}}}],"title":"Cases Stop Dropping and the Midwest Heats Up: This Week in COVID-19 Data, Sep 3","lede":{"lede":"After five straight weeks of sharp declines in new cases of COVID-19 in the United States, we’ve leveled off again. Reported tests are up about 5 percent, but are actually dropping in the Midwest, where three states—Iowa, North Dakota, and South Dakota—are driving an uptick in new cases. This week we also launched a new dataset that looks closely at the toll of COVID-19 in nursing homes and other long-term care facilities."}},{"slug":"something-is-wrong-with-testing-data-in-the-great-state-of-texas","publishDate":"August 14, 2020","authors":[{"name":"Conor Kelly","twitterLink":"https://twitter.com/CohoKelly","twitterHandle":"CohoKelly","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Conor Kelly is the director of data analytics at Hanover Research.</p>"}},"headshot":{"file":{"fileName":"0.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/69bo9CT4zaWlhgPWsbryGC/9125242dc83bec36e78214580f96b97d/0.jpg?w=200&fl=progressive&q=50"}}},{"name":"Judith Oppenheim","twitterLink":null,"twitterHandle":null,"link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Judith Oppenheim works on Texas City Data and state outreach at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Auto-uploaded image (4) at 2020-08-14 17:08:15"},"resize":{"width":200,"height":204,"src":"//images.ctfassets.net/o2ll9t4ee8tq/75wajv7WUWOJosoUpXskcg/5169499f0818033f4373750bcb5c6995/Auto-uploaded_image__4__at_2020-08-14_17_08_15?w=200&fl=progressive&q=50"}}},{"name":"Pat Kelly","twitterLink":"https://twitter.com/n_pat_kelly","twitterHandle":"n_pat_kelly","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Pat Kelly is a technology executive and entrepreneur based in Austin, Texas, and works on The COVID Racial Data Tracker and The Long-Term Care COVID Tracker at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Auto-uploaded image (1) at 2020-08-14 17:15:11"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/35BwZgFwiVXYOs8WlcqhUK/037ac1655bf7a213731abbbbdba4075a/Auto-uploaded_image__1__at_2020-08-14_17_15_11?w=200&fl=progressive&q=50"}}}],"title":"Something Is Wrong with Testing Data in the Great State of Texas ","lede":{"lede":"According to the official state numbers, COVID-19 testing has dropped dramatically in August. However, county-level statistics show the opposite story. What’s going on? "}},{"slug":"tests-cases-and-hospitalizations-keep-dropping","publishDate":"August 13, 2020","authors":[{"name":"Alexis Madrigal","twitterLink":"https://twitter.com/alexismadrigal","twitterHandle":"alexismadrigal","link":"https://www.theatlantic.com/author/alexis-madrigal","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Alexis C. Madrigal is a staff writer at The Atlantic, a co-founder of the COVID Tracking Project, and the author of <em>Powering the Dream: The History and Promise of Green Technology</em>.</p>"}},"headshot":{"file":{"fileName":"original.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3vW1aeLjPFSMAZOqHv9TQS/b4ffb03526cf67724c6732c6e11a6cef/original.png?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"Tests, Cases, and Hospitalizations Keep Dropping: This Week in COVID-19 Data, Aug 13","lede":{"lede":"Testing continues to fall, especially in the South, one of the areas where the country needs it the most. Cases, too, are falling, which remains hard to interpret, given the testing decline—but fewer people are now in the hospital with COVID-19 than last week. This is the second week in a row that hospitalizations seem to have dropped, which suggests that infections may be declining independently of testing reductions."}},{"slug":"floridas-per-capita-covid-19-cases-just-surpassed-new-yorks","publishDate":"July 31, 2020","authors":[{"name":"Júlia Ledur","twitterLink":"https://twitter.com/juledurg","twitterHandle":"juledurg","link":"https://www.linkedin.com/in/j%C3%BAlia-ledur/en-us","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Júlia Ledur is a visual journalist and illustrator who leads the visualization team at The COVID Tracking Project. She is a former graphics reporter at Reuters. </p>"}},"headshot":{"file":{"fileName":"L6YFpyfj_400x400.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3Ti7VtyPTSUAi9RKRhu4sS/537660d90a09e2329d8a7ab9fbc657a6/L6YFpyfj_400x400.jpg?w=200&fl=progressive&q=50"}}},{"name":"Emma Rubin","twitterLink":"https://twitter.com/Emmanrubin","twitterHandle":"emmanrubin","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Emma Rubin is a recent college graduate and freelance journalist.</p>"}},"headshot":{"file":{"fileName":"IMG-4758.JPG"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/vcBpRlR1NGM8jo3StodPo/5e49a221cf016a9af4afbeee48c7fa90/IMG-4758.JPG?w=200&fl=progressive&q=50"}}}],"title":"Florida’s Per-Capita COVID-19 Cases Just Surpassed New York’s, but Are the Two Outbreaks Comparable? Yes and No.","lede":{"lede":"Florida has reported over 461,000 total COVID-19 cases, surpassing New York for the highest per-capita caseload in the United States—but a simple comparison doesn’t represent the critical differences in the data we have for the two outbreaks. "}},{"slug":"record-new-cases-surging-hospitalizations-rising-deaths-this-week-in-covid","publishDate":"July 9, 2020","authors":[{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Alice Goldfarb","twitterLink":"https://twitter.com/afgoldfarb","twitterHandle":"afgoldfarb","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Alice Goldfarb leads The COVID Tracking Project’s part in The COVID Racial Data Tracker, and is a Nieman Visiting Fellow.</p>"}},"headshot":{"file":{"fileName":"image.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/5W49v2mwQyV13xAkZp5hcT/f3b4f6a060b70ac56e5a5c3727178844/image.jpg?w=200&fl=progressive&q=50"}}}],"title":"Record New Cases, Surging Hospitalizations, Rising Deaths: This Week in COVID-19 Data, July 9","lede":{"lede":"The South continues to be the epicenter of surges in both cases and hospitalizations. In Arizona, Florida, South Carolina, and Texas, COVID-19 deaths have begun to climb following jumps in new cases. And for the first time since April, deaths are rising nationally."}},{"slug":"this-week-in-covid-19-data-july-2","publishDate":"July 2, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Alexis Madrigal","twitterLink":"https://twitter.com/alexismadrigal","twitterHandle":"alexismadrigal","link":"https://www.theatlantic.com/author/alexis-madrigal","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Alexis C. Madrigal is a staff writer at The Atlantic, a co-founder of the COVID Tracking Project, and the author of <em>Powering the Dream: The History and Promise of Green Technology</em>.</p>"}},"headshot":{"file":{"fileName":"original.png"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/3vW1aeLjPFSMAZOqHv9TQS/b4ffb03526cf67724c6732c6e11a6cef/original.png?w=200&fl=progressive&q=50"}}}],"title":"This Week in COVID-19 Data, July 2: Across the US, Outbreaks Are Catching Fire","lede":{"lede":"The US has broken its record for new COVID-19 cases three times in the last week. Thirteen states broke their new-case records since Sunday. In the states with the worst outbreaks, hospitalizations and deaths are rising."}},{"slug":"weekly-covid-19-data-update-june-25-the-us-pandemic-is-surging","publishDate":"June 25, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"Weekly COVID-19 Data Update, June 25: The US Pandemic Is Surging in the South and West","lede":{"lede":"The United States hit a record high for new COVID-19 cases this week. In many areas with rising case counts, testing isn’t keeping up. Meanwhile, hospitalizations in regions with big outbreaks are increasing."}},{"slug":"weekly-covid-19-data-update-june-18-the-regional-gap-widens","publishDate":"June 18, 2020","authors":[{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}}],"title":"Weekly COVID-19 Data Update, June 18: The Regional Gap Widens","lede":{"lede":"As cases and hospitalizations continue to drop in the early Northeast epicenters, they are rising—in some areas quite sharply—in the South and West. We look at the numbers and at the relationship between an increase in tests and a rise in case counts."}},{"slug":"weekly-covid-19-data-update-june-11-early-data-from-may-transmission","publishDate":"June 11, 2020","authors":[{"name":"Peter Walker","twitterLink":"https://twitter.com/PeterJ_Walker","twitterHandle":"PeterJ_Walker","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Peter Walker is Head of Marketing &#x26; Growth at <a href=\"http://publicrelay.com\">PublicRelay</a> and Data Viz Co-Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"peter_walker.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/1dAn50ABHS2PHyoE9D8FiT/64f122540f69ad851d3b4685182d6299/peter_walker.jpg?w=200&fl=progressive&q=50"}}},{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}}],"title":"Weekly COVID-19 Data Update, June 11: Early Data from May Transmission","lede":{"lede":"The news this week is mixed and highly regional. In the early US epicenter of the outbreak, cases continue to drop. In the southern and western United States, cases are on the rise, as are COVID-19 hospitalizations. And as always, the lag makes the data difficult to put into context."}},{"slug":"what-is-a-probable-case-of-covid-19","publishDate":"June 17, 2020","authors":[{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}},{"name":"Quang P. Nguyen","twitterLink":"https://twitter.com/quangpmnguyen","twitterHandle":"quangpmnguyen","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Quang P. Nguyen is a PhD candidate in the Department of Epidemiology at Dartmouth College.</p>"}},"headshot":{"file":{"fileName":"Quang.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2XwoiQ3eBUJl7Fyeh4qi4Y/1f8e82642e28d279dbffa1d6a7c6af09/Quang.jpg?w=200&fl=progressive&q=50"}}}],"title":"What Is a Probable Case of COVID-19?","lede":{"lede":"Probable cases of COVID-19 make up only a small fraction of currently reported cases, but the CDC wants states to do a better job reporting them. So what are they and why do they matter? We took a closer look to help reporters and members of the public better understand this complex COVID-19 metric."}},{"slug":"tracking-cdc","publishDate":"May 20, 2020","authors":[{"name":"Jessica Malaty Rivera","twitterLink":"https://twitter.com/jessicamalaty","twitterHandle":"jessicamalaty","link":"https://www.linkedin.com/in/jessicamalaty/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Jessica Malaty Rivera has an MS in Emerging Infectious Diseases and is the Science Communication Lead at The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"Headshot_JMR 0420.png"},"resize":{"width":200,"height":186,"src":"//images.ctfassets.net/o2ll9t4ee8tq/01oVW5ijttftH45bYeHoxH/eb6b776ab23d21efc4ad123be1bcf2c2/Headshot_JMR_0420.png?w=200&fl=progressive&q=50"}}},{"name":"Amber Wojcek","twitterLink":"https://twitter.com/ambie_whoa","twitterHandle":"ambie_whoa","link":"https://www.linkedin.com/in/amberwojcek/","childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Amber Wojcek is a B2B marketing director in Sanford, Florida, and a contributor to The COVID Tracking Project.</p>"}},"headshot":{"file":{"fileName":"TUPV6BFR9-U012RTCDP0X-777e3cad45f1-512.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/5NDZw1ZgOq80viBpzF7vp1/0b47ecab43c9dee04b4e46b13c1667c2/TUPV6BFR9-U012RTCDP0X-777e3cad45f1-512.jpg?w=200&fl=progressive&q=50"}}}],"title":"Tracking the States and the CDC","lede":{"lede":"For months, we've worked to patch together inconsistent state-reported data into a national set of numbers for COVID-19 case, death, and testing in the US. The CDC has now published a COVID Data Tracker, but their data only partially matches the numbers we get from the state public health authorities. So we took a closer look."}},{"slug":"antibody-data-reporting","publishDate":"May 14, 2020","authors":[{"name":"Quang P. Nguyen","twitterLink":"https://twitter.com/quangpmnguyen","twitterHandle":"quangpmnguyen","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Quang P. Nguyen is a PhD candidate in the Department of Epidemiology at Dartmouth College.</p>"}},"headshot":{"file":{"fileName":"Quang.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2XwoiQ3eBUJl7Fyeh4qi4Y/1f8e82642e28d279dbffa1d6a7c6af09/Quang.jpg?w=200&fl=progressive&q=50"}}},{"name":"Erin Kissane","twitterLink":"https://twitter.com/kissane","twitterHandle":"kissane","link":null,"childContentfulAuthorBiographyTextNode":{"childMarkdownRemark":{"html":"<p>Erin Kissane is a co-founder of the COVID Tracking Project, and the project’s managing editor. </p>"}},"headshot":{"file":{"fileName":"aea_speaker_erin-kissane_profile-1.jpg"},"resize":{"width":200,"height":200,"src":"//images.ctfassets.net/o2ll9t4ee8tq/2WCYvp5xysZve5yeyurzES/0fee217257ef4d15fdead7b811310be7/aea_speaker_erin-kissane_profile-1.jpg?w=200&fl=progressive&q=50"}}}],"title":"Position Statement on Antibody Data Reporting","lede":{"lede":"As antibody tests become more widely available across the United States, we call on all states and territories to preserve the integrity and usefulness of their COVID-19 testing data by maintaining separate viral testing and antibody testing counts."}}]}],"blogContent":{"raw":"{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"When SARS-CoV-2 (the virus that causes COVID-19) first emerged, public health officials across the US had some quick work to do. First, they needed to learn enough about the virus to understand how and when to test for its presence. Next came manufacturing needs, and the distribution of tests. Data pipelines had to be built, to funnel diagnostic test results up from labs, and all of this needed to happen as fast as humanly possible.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"What health officials also knew was that they needed a way to tell if someone \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"probably\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" had COVID-19—a way to account for the situations of virus spread among individuals who weren’t being tested. So, in April 2020, the CDC \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-01_COVID-19_NO.pdf\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"adopted a definition\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" for probable COVID-19 cases. The definition was based on exposure and symptoms, and it was an attempt to signal to state health officials that there could be one standardized way to interpret a \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"probable\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"case.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"In those early months, probable cases comprised only a small fraction of the national case count, likely because the probable case definition relied on contact tracing and symptom tracking, which were difficult for states to perform at scale. Then, as antigen tests became more widely available and able to quickly identify COVID-19 with a high degree of certainty, the CDC expanded the probable case definition to make room for antigen test results, even in the absence of exposure and symptoms. It was only with this \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"expanded definition\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\", adopted in August 2020, that probable cases made a dent in the national case volume.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"As we’ve seen across the range of COVID-19 metrics, though, just because there was (some) federal guidance didn’t mean states were following it. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"With probable cases, how and when states chose to incorporate the CDC’s guidance varied. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"By now, most states do use a probable case definition that includes antigen positive individuals, but there are still a few outlier states using different or unclear definitions. It is this veneer of uniformity— these quiet definitional discrepancies and the varying journeys states took toward similar conclusions—that this piece will explore.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Current definitions: confirmed, probable, and suspect cases of COVID-19\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-2\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"To track any infectious disease, you need what’s called a “surveillance definition,” a set of criteria used to measure the spread of a disease on a large scale (rather than making individual clinical diagnoses).\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" The Council of State and Territorial Epidemiologists (CSTE) sets the surveillance definitions used by CDC for many infectious diseases, and COVID-19 was no exception: The organization has issued two iterations of definitional guidelines for COVID-19 cases since the pandemic began\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\", in \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-01_COVID-19_NO.pdf\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"April 2020\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" and \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-02_COVID-19.pdf\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"August 2020\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\", that were adopted by the CDC \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://cdn.ymaws.com/www.cste.org/resource/resmgr/pdfs/Letter_to_CSTE_on_Interim-20.pdf\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"shortly\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/20-id-02_Case_Def_Aug_19_202.pdf\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"thereafter\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\". The current guidelines call for states and the CDC to track three categories of COVID-19 cases—confirmed cases, probable cases, and suspect cases. The CSTE recommends that states track confirmed and probable cases publicly, while suspect cases are meant as an internal category for disease surveillance. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"3RgdbM3fWKRv6vrdc8yeeh\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Confirmed cases\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-4\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Confirmed cases of COVID-19 are the most straightforward: When a PCR test comes back positive, the individual is declared a confirmed case. PCR tests are often referred to as \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://covidtracking.com/analysis-updates/test-types-101\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"“gold standard tests” for COVID-19\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" because of their high sensitivity, which means PCR tests are able to pick up even very small amounts of viral RNA, even early in an infection. There is a low chance for false positives.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Probable cases\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-4\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Probable cases can be identified in three main ways. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The primary way currently uses antigen testing, which is generally known to have lower sensitivity than PCR or other viral RNA detection tests. A person with a low level of viral infection might get a false negative result. However, antigen tests are highly \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"specific \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"tests\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\", \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"meaning that false positive results are unlikely. Because these tests are cheaper than PCR tests and produce results much more quickly, they can be used to rapidly identify individuals with high levels of virus who are likely to infect others.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The second way to identify a probable case is through symptoms (clinical criteria) and likely exposure (epidemiological linkage). In other words, if an individual is experiencing certain symptoms known to be associated with COVID-19, and they were in a situation where they had known exposure to a probable or confirmed case, they could be classified as a probable case without a test result or with a test result pending.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Finally, deceased individuals with COVID-19 listed on a death certificate as the presumed cause of death or significant condition contributing to death and without a positive laboratory result can be classified as a probable case. This is different from being classified as a probable COVID-19 death—though the COVID-19 case definitions are often used by jurisdictions to determine COVID-19 deaths as well. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The diagram below illustrates the specific combinations of criteria that the CSTE says should be used to classify a case as probable in the absence of a laboratory test result:\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"7hX6z5Myz3JEQEsYpMBqiO\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Suspect cases\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-4\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"In the hierarchy of case classification, suspect cases represent individuals with the lowest level of evidence that they are presently infected with COVID-19. These individuals may have a positive antibody test—indicating past infection, but probably not a current infection. The CSTE recommends that states and the CDC keep track of these individuals internally but not include them in public COVID-19 case counts.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"What changed? The evolution of case definitions\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-2\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"As mentioned, the current CSTE case definition is the second iteration, an update on the original one from April 2020. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"While the definition of a confirmed case did not change with the updated version, the definition of a probable case was adjusted to reflect the growing understanding of COVID-19’s clinical presentation, patterns of spread, and changing availability of lab tests.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"To understand the changes, it’s helpful to know how CSTE case classifications work. Each case classification is made up of a set of criteria: laboratory criteria, clinical criteria, epidemiological factors, and the vital records criteria. This can all be combined to standardize what it means to identify a confirmed or probable case of COVID-19.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"Laboratory criterion changes\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-4\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Between April and August 2020, the most significant changes were to the laboratory criterion: \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"7lSN9E1tV2VFOd97CRzVJc\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"Changes in how the criterion can be used:\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" Beginning in August, laboratory evidence on its own—absent any other criteria—indicated a probable case. (The original April 2020 definition required clinical or epidemiological criteria to be satisfied, as well, in order to be considered a probable case.) \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"Changes to the criterion itself: \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"Antibody tests were removed as laboratory evidence, leaving only antigen tests. The internal (not public) suspect cases category was added as a new category for patients who tested positive on antibody tests.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"}],\"nodeType\":\"ordered-list\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"As antigen tests became more prevalent, they proved to be highly reliable at indicating active COVID-19 infections. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"Meanwhile, unlike both antigen and PCR tests, antibody tests identify \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"prior \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"rather than \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"current \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"infections. They detect the presence of specific antibodies, and according to the CDC, \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://www.cdc.gov/coronavirus/2019-ncov/testing/serology-overview.html\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"it can take one to three weeks\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" after the infection for your body to produce detectable antibodies. For that reason, antibody tests are not appropriate for diagnosing probable or confirmed cases of COVID-19.  \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"Epidemiological and clinical criteria\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-4\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The epidemiological linkage criteria were adjusted to reflect a better understanding of COVID-19 transmission:\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The updated definition does not require close contact with someone who is sick with a COVID-19-like illness and linked to a confirmed COVID-19 case, reflecting an understanding that asymptomatic transmission of COVID-19 is common.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"In addition, travel to an area outside of the US with sustained, ongoing community transmission of COVID-19 was removed as a necessary epidemiological linkage factor, as most of the United States itself could be described as having sustained ongoing community transmission.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"}],\"nodeType\":\"unordered-list\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"2x5fa9g1q4yAIViWLo8VLJ\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Definitions of \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"clinical criteria\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" were also modified as COVID-19 symptoms became better understood. Most notably, in the original probable case definition, the loss of taste and smell needed to be present with other symptoms, whereas the updated definition counted the loss of taste and smell (olfactory disorder) as a COVID-19 symptom on its own. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"In addition, the symptoms listed in the original definition were almost exclusively respiratory. However, as more and more people presented with gastrointestinal symptoms and extreme fatigue, these additional symptoms were also added to the list of possible COVID-19 symptoms. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"1GI3t0D77wGPU6aQCghev2\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"How did these changes affect the data?\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-2\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The Covid Tracking Project’s work has focused on understanding and contextualizing COVID-19 data, so we wanted to take a closer look at the probable cases states reported. Namely, \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"we wanted to see what, if any, impact the CSTE’s definitional changes made to the data that was reported.\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" Our research was driven by these questions: \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"We knew when CSTE updated the case definition for probable cases, but when did states actually adopt the updated definition?\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Did the updated definition have an impact on the number of probable cases that were being reported?\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"},{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Were those effects the same across states?\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"list-item\"}],\"nodeType\":\"unordered-list\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Our analysis looked at data gathered during our year of daily data collection, which stopped on March 7, 2021, and shows that \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"as of March 7, 2021 the reporting of probable cases was still very uneven across the country. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"Six states—California, Iowa, Maryland, Missouri\",\"nodeType\":\"text\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"0WGydn9UxpBvgM5gqd2A5\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-inline\"},{\"data\":{},\"marks\":[],\"value\":\", Nevada, and the Northern Mariana Islands—did not report probable cases. Among states that did report probable cases, \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"most converged on using the updated case definitions in the fall of 2020, but there’s regional variation in how the definitions have been implemented and interpreted. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"States’ adoption of CSTE-02 definitions\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-3\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Of the 55 states and territories we tracked, 36 had been providing separate counts of confirmed and probable cases as of March 7, 2021.\",\"nodeType\":\"text\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"42DQCOUzKhZq58qEOMdOz7\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-inline\"},{\"data\":{},\"marks\":[],\"value\":\" (\",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://covidtracking.com/analysis-updates/what-is-a-probable-case-of-covid-19/\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"When we previously wrote on this topic\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\", in June 2020, we identified only 25 states providing separate counts.)\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Of the remaining states, seven reported combined confirmed and probable cases, six states reported confirmed cases only, and six states reported cases with an unclear definition.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"5shdbikcBNGrphi2ZPKvpP\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Of the 36 states that report confirmed and probable cases separately, 35 used the updated (CSTE-02) definition as adopted by the CDC in August 2020. One state, Vermont, uses a custom probable case definition. Most states that switched to the updated definition moved in September and October 2020, though two of those states, Delaware and Mississippi, still display the original case definition on their dashboards. (We reached out to officials at Delaware’s Department of Health and Social Services, who confirmed that they are using the updated definition and said they will be updating the language. A spokesperson from Mississippi’s Department of Health said they weren’t aware the previous case definition was on the state’s website but confirmed use of CSTE-02.)\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Trends in probable case reporting\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-3\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"It’s important to remember that the number of COVID-19 cases will never be a measurement of the number of infections, in part due to the fact that many people across the country, and particularly people in communities hit hard by COVID-19, might not have had easy access to PCR or antigen tests, or might have decided against seeking one. Still, probable case numbers aren’t insignificant. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"Given the trends we’re seeing from states that do separately report probable and confirmed cases, we can assume that in the six states reporting confirmed cases only, large numbers of would-be probable cases aren’t making it into any public-facing official count. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"Indeed, our analysis shows that starting in the fall of 2020, an overall increase in the number of probable cases appears in almost every state. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"Our analysis also looked at whether the proportion of probable cases as a share of total reported cases changed over the course of the pandemic. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"An increase in the proportion of probable cases would indicate that states were more efficiently tracking probable cases compared to summer of 2020. If the proportion of probable cases did not increase in the total number of cases, that means the increase in the number of probable cases was simply an artifact of increased cases as a whole.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"We looked at the 21 states and territories that reported probable and confirmed cases separately and for which we’ve collected continuous data from August 5, 2020—the day the updated CSTE definition was issued—until March 7, 2021.\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" We found a growing share of probable cases, by as much as 20x in a few states:\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"5TGgaBB2RxTULi4HQQxBqo\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Differences in interpretation and use between states\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-3\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"There’s no denying that the decision to count antigen positive test results as probable cases contributed to the growth of probable numbers, but\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" the extent to which antigen tests alone drove that growth isn’t easy to parse.\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" Given the varying definitions across states, it’s especially difficult to interpret this data.\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" In some states, a probable case of COVID-19 translates to an antigen positive test result unequivocally; in others, broader symptomatic and epidemiological criteria has played a role in defining the probable count.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"(A quick word of caution, too: It’s important to remember that with many antigen tests happening outside of traditional healthcare settings, \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://khn.org/news/lack-of-antigen-test-reporting-leaves-country-blind-to-the-pandemic/\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"the data reporting pipelines might not be set up\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" to actually send all antigen test results to state officials.)\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"There are nine states that report both probable cases and either antigen positive individuals or antigen positive tests—and report them all smoothly enough and for a long enough period that we can spot meaningful trends.\",\"nodeType\":\"text\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"20UMQrPJuAs7hFGAwvD1fB\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-inline\"},{\"data\":{},\"marks\":[],\"value\":\" Out of those nine states, five—Arkansas, Connecticut, Tennessee, Maine, and Virginia—have probable cases that very closely track trends in antigen positive test results. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Our suspicion is that in these states, \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"officials are identifying probable cases only (or almost entirely) through antigen tests, and we suspect these decisions were made because the scale of the pandemic grew too large to track symptomatic and epidemiological criteria in a meaningful enough way\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\".\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"4Mc7UC2CDyAPSeYJN8PVYZ\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Four additional states—Florida, Georgia, Indiana, and Louisiana—have notes on their websites about using only antigen tests to identify probable cases. And one more state, Massachusetts, decided to use only antigen tests and death certificates on September 2, 2020, cutting cases that only met the clinical and epidemiological criteria out of its count. \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://www.mass.gov/doc/covid-19-dashboard-september-2-2020/download\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"A note from the state about the definitional shift\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" provided some insight into their decision: “In order to provide a single set of consistent data for tracking COVID-19 in Massachusetts, today’s data includes only probable cases identified through antigen testing or death certificates. These criteria are the most objective and able to be applied over time.” \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"That day, \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://covidtracking.com/data/state/massachusetts/cases\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"we noticed a sharp decrease in several data points\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" for Massachusetts; the state’s overall case count dropped by more than 7,000.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"There are four states—Kentucky, Ohio, South Carolina, and Texas—where trends in antigen positives do not closely track probable case counts. In three of those four states, all except South Carolina, the antigen test numbers have largely been lower than probable cases.\",\"nodeType\":\"text\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"3W7XubcjnI20L8z1XeWohI\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-inline\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"There are a handful of possible explanations for these discrepancies. It is possible that some of the difference could be due to sourcing between test and case metrics: for example, states could be only reporting \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://covidtracking.com/analysis-updates/silent-data-mismatches-are-compromising-key-covid-19-indicators/\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"electronically transmitted antigen tests\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\" but also including faxed reports in probable case counts. But most likely, this difference reflects use of the symptomatic and epidemiological criteria—as Texas officials confirmed it did in their state.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{\"target\":{\"sys\":{\"id\":\"4sN4IldGjQ0LsgSXVFgJhV\",\"type\":\"Link\",\"linkType\":\"Entry\"}}},\"content\":[],\"nodeType\":\"embedded-entry-block\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"You might think that the decision to track only antigen-identified probable cases would result in an undercount of cases overall—especially given that removing the symptomatic and epidemiological criteria initially led to such a large drop in Massachusetts. But probable cases grew as a share of total cases by a comparable amount in these two groups of states between November 1, 2020 and March 7, 2021—approximately doubling in both the states where probable cases \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"don’t\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\" track with antigen positives and in the states where they do.  \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"The near identical growth in both groups leads us to believe that state testing strategies played an important role in shaping probable case counts\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\": The states that dropped the symptomatic and epidemiological criteria likely have strong enough antigen testing programs to pick up on those individuals through testing, anyway. Identifying probable cases from just contact tracing and symptom exposure was a laborious task for state health departments, especially at scale, so with the rise in the availability of antigen tests, health departments had a more efficient method.\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"This research serves as a reminder that even if all states \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"},{\"type\":\"italic\"}],\"value\":\"were\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" to be using standardized definitions, comparisons would still be fraught due to differences in infrastructure and testing strategies. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Probable cases are real COVID-19 cases\",\"nodeType\":\"text\"}],\"nodeType\":\"heading-2\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Like so many COVID-19 data points, \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"the probable cases metric is complex, and to interpret it accurately requires an understanding of its definition, practical application, and evolution. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"This is all especially important in a context where the difference between the number of cases and the number of positive PCR tests has become a common source of confusion and of disinformation—with some alleging that counting probable cases inflates case numbers. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The reasons for tracking probable cases aren’t obvious, nor are they consistent across states, but\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" the differences stem from legitimate decision-making rooted in epidemiology\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\", not from anything nefarious or negligent. Given the high specificity of COVID-19 antigen tests, it’s entirely reasonable for states to be counting these positive test results as probable cases. In fact, \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"underline\"}],\"value\":\"in many countries\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[],\"value\":\", an antigen positive constitutes a confirmed COVID-19 case.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The share of probable cases in the US’s overall COVID-19 case count didn’t grow because state health officials were itching to count just anybody. It grew because \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\"as the country’s understanding of COVID-19 and capabilities around testing for it evolved, so too did the ability to paint a fuller picture. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"There is no reason to be concerned that probable case counts are inflated;\",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\" if anything, both confirmed and probable case counts, largely at the mercy of \",\"nodeType\":\"text\"},{\"data\":{\"uri\":\"https://www.npr.org/sections/health-shots/2020/12/22/948085513/vaccines-are-coming-but-the-u-s-still-needs-more-testing-to-stop-the-surge\"},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"bold\"},{\"type\":\"underline\"}],\"value\":\"inadequate testing\",\"nodeType\":\"text\"}],\"nodeType\":\"hyperlink\"},{\"data\":{},\"marks\":[{\"type\":\"bold\"}],\"value\":\", underestimate the true scale of COVID-19 infections in the United States. \",\"nodeType\":\"text\"},{\"data\":{},\"marks\":[],\"value\":\"\\n\\n\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"Additional research: Michal Mart, Jessica Malaty Rivera\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[{\"type\":\"italic\"}],\"value\":\"Graphics: Dave Luo, Kara Schechtman, Lauran Hazan\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"document\"}","references":[{"__typename":"ContentfulContentBlockImage","id":"40649938-1471-52ca-8fd4-bc0d7fc91597","contentful_id":"3RgdbM3fWKRv6vrdc8yeeh","keepSize":null,"fullWidthMobile":null,"caption":null,"imageLink":null,"childContentfulContentBlockImageLongCaptionTextNode":null,"image":{"file":{"url":"//images.ctfassets.net/o2ll9t4ee8tq/73DzIHFH2o3rKOXGMSYvlp/1d25efe9004cca7c195d2c4e149d8d0d/image6.png"},"title":"CSTE flow chart","description":"A flow chart shows the classification of confirmed, probable and suspect COVID-19 cases following the most recent CSTE case definition. Confirmed cases are identified with a positive PCR tests, probable cases with either a positive antigen test or satisfying both clinical and epidemiologic criteria, and suspect cases with a positive antibody test.","fluid":{"aspectRatio":1.6385245901639345,"sizes":"4","src":"//images.ctfassets.net/o2ll9t4ee8tq/73DzIHFH2o3rKOXGMSYvlp/1d25efe9004cca7c195d2c4e149d8d0d/image6.png?w=2000&q=50","srcSet":"//images.ctfassets.net/o2ll9t4ee8tq/73DzIHFH2o3rKOXGMSYvlp/1d25efe9004cca7c195d2c4e149d8d0d/image6.png?w=500&h=305&q=50 500w,\n//images.ctfassets.net/o2ll9t4ee8tq/73DzIHFH2o3rKOXGMSYvlp/1d25efe9004cca7c195d2c4e149d8d0d/image6.png?w=1000&h=610&q=50 1000w,\n//images.ctfassets.net/o2ll9t4ee8tq/73DzIHFH2o3rKOXGMSYvlp/1d25efe9004cca7c195d2c4e149d8d0d/image6.png?w=1999&h=1220&q=50 1999w"}}},{"__typename":"ContentfulContentBlockImage","id":"1e861bc3-b08f-5a90-abdd-701e932dff75","contentful_id":"7hX6z5Myz3JEQEsYpMBqiO","keepSize":null,"fullWidthMobile":null,"caption":null,"imageLink":null,"childContentfulContentBlockImageLongCaptionTextNode":null,"image":{"file":{"url":"//images.ctfassets.net/o2ll9t4ee8tq/h3n4GyELfiDF2VCr6zFzJ/d65ca13d570b82a7333114a9f078d03d/image4.png"},"title":"Probable cases venn diagram","description":"A venn diagram illustrates the combination of criteria that are necessary to identify a probable case of COVID-19 without a positive antigen test. Individuals must have had both recent close contact with a COVID-19 case, and either one definitive COVID-19 symptom or at least two possible COVID-19 symptoms.","fluid":{"aspectRatio":1.427857142857143,"sizes":"4","src":"//images.ctfassets.net/o2ll9t4ee8tq/h3n4GyELfiDF2VCr6zFzJ/d65ca13d570b82a7333114a9f078d03d/image4.png?w=2000&q=50","srcSet":"//images.ctfassets.net/o2ll9t4ee8tq/h3n4GyELfiDF2VCr6zFzJ/d65ca13d570b82a7333114a9f078d03d/image4.png?w=500&h=350&q=50 500w,\n//images.ctfassets.net/o2ll9t4ee8tq/h3n4GyELfiDF2VCr6zFzJ/d65ca13d570b82a7333114a9f078d03d/image4.png?w=1000&h=700&q=50 1000w,\n//images.ctfassets.net/o2ll9t4ee8tq/h3n4GyELfiDF2VCr6zFzJ/d65ca13d570b82a7333114a9f078d03d/image4.png?w=1999&h=1400&q=50 1999w"}}},{"__typename":"ContentfulContentBlockTable","id":"20ffc955-e6e7-583c-ab66-7c2ebe5bb3d7","contentful_id":"7lSN9E1tV2VFOd97CRzVJc","table":{"table":"|                   | April 5, 2020  (CSTE-01)                                                                                    | August 5, 2020 (CSTE-02)                                          |\n|-------------------|-------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------|\n| Positive antigen  | Detection of specific antigen in a clinical specimen  **AND accompanied by clinical or epidemiologic criteria | Detection of SARS-CoV-2 by antigen test in a respiratory specimen** |\n| Positive antibody | Detection of specific antibody in serum, plasma, or whole blood indicative of a new or recent infection     | **No longer considered a probable case**                             |"},"caption":null},{"__typename":"ContentfulContentBlockTable","id":"ed3da4d9-a6a8-5112-ab52-1ef6655e8018","contentful_id":"2x5fa9g1q4yAIViWLo8VLJ","table":{"table":"|                                        | April 5, 2020  (CSTE-01)                                                                                                  | August 5, 2020 (CSTE-02)                                                            |\n|----------------------------------------|---------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------|\n| Contact with Case                      | Close contact (within six feet for 15 consecutive minutes or more) with a confirmed or probable case of COVID-19 disease; | Close contact with a confirmed or probable case of COVID-19 disease;                |\n| Contact with Ill person linked to case | Close contact with a person with: clinically compatible illness AND linkage to a confirmed case of COVID-19 disease.      | Removed                                                                             |\n| Travel to hi-transmission              | Travel to or residence in an area (outside of the US) with sustained, ongoing community transmission of SARS-CoV-2.       | Removed                                                                             |\n| Risk Cohort                            | Member of a risk cohort as defined by public health authorities during an outbreak.                                       | Member of a risk cohort as defined by public health authorities during an outbreak. |"},"caption":null},{"__typename":"ContentfulContentBlockTable","id":"26a1e94c-d73c-5019-8ce8-0d04e06bdb2f","contentful_id":"1GI3t0D77wGPU6aQCghev2","table":{"table":"| April 5, 2020  (CSTE-01)                                                                                                                                      | August 5, 2020 (CSTE-02)                                                                                                                                              |\n|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|\n| _At least two_ of the following symptoms: fever, chills, rigors, myalgia, headache, sore throat,  **new olfactory and taste disorder(s)**                     | _At least two_ of the following symptoms: fever, chills, rigors, myalgia, headache, sore throat,  **nausea or vomiting, diarrhea, fatigue, congestion or runny nose** |\n| OR _at least one_ of the following symptoms: cough, shortness of breath, or difficulty breathing                                                                 | OR _any one_ of the following symptoms: cough, shortness of breath, difficulty breathing,  **new olfactory disorder,new taste disorder**                                 |\n| OR severe respiratory illness with at least one of the following: clinical or radiographic evidence of pneumonia, OR acute respiratory distress syndrome (ARDS). | OR severe respiratory illness with at least one of the following: clinical or radiographic evidence of pneumonia, OR Acute respiratory distress syndrome (ARDS).         |"},"caption":null},{"__typename":"ContentfulContentBlockFootnote","id":"bd3685f3-fe1e-50bc-a7dd-6d2e097b50a0","contentful_id":"0WGydn9UxpBvgM5gqd2A5","footnote":{"footnote":"After our data collection stopped on March 7, 2021, Missouri began publishing a separate count of probable cases."}},{"__typename":"ContentfulContentBlockFootnote","id":"6f0540a4-825e-5eb0-a6df-6d6d2299e325","contentful_id":"42DQCOUzKhZq58qEOMdOz7","footnote":{"footnote":"Our daily data collection also looked at American Samoa, which we did not include in this analysis for the very best reason: The COVID Tracking Project never reported a single COVID-19 case for American Samoa."}},{"__typename":"ContentfulContentBlockImage","id":"e0e6648f-dc56-5b4e-a0a5-60321e663cda","contentful_id":"5shdbikcBNGrphi2ZPKvpP","keepSize":null,"fullWidthMobile":null,"caption":null,"imageLink":null,"childContentfulContentBlockImageLongCaptionTextNode":{"childMarkdownRemark":{"rawMarkdownBody":"These classifications are based on information from state websites and The COVID Tracking Project’s outreach to state health departments. They can be viewed in spreadsheet form [here](https://docs.google.com/spreadsheets/d/e/2PACX-1vQ6kFI2hhLTiSVV_9dd6zdPSIjo_M8GpAM4seBYoNW5We95vMQy6W-OXoMwz82jfcGCfXneBAN_-v5B/pubhtml?gid=1402690440&single=true). \n"}},"image":{"file":{"url":"//images.ctfassets.net/o2ll9t4ee8tq/4Jv333ImxtKTXHdpjX7zeJ/601c1236f80438557c05e4f9f942ad94/image5.png"},"title":"Map with state reporting of probable cases","description":"A map shows which states report confirmed and probable cases together, which states report a breakdown and which probable case definition they are using, which states report confirmed cases only, and which states have an unclear case definition as of March 7, 2021.","fluid":{"aspectRatio":1.999,"sizes":"4","src":"//images.ctfassets.net/o2ll9t4ee8tq/4Jv333ImxtKTXHdpjX7zeJ/601c1236f80438557c05e4f9f942ad94/image5.png?w=2000&q=50","srcSet":"//images.ctfassets.net/o2ll9t4ee8tq/4Jv333ImxtKTXHdpjX7zeJ/601c1236f80438557c05e4f9f942ad94/image5.png?w=500&h=250&q=50 500w,\n//images.ctfassets.net/o2ll9t4ee8tq/4Jv333ImxtKTXHdpjX7zeJ/601c1236f80438557c05e4f9f942ad94/image5.png?w=1000&h=500&q=50 1000w,\n//images.ctfassets.net/o2ll9t4ee8tq/4Jv333ImxtKTXHdpjX7zeJ/601c1236f80438557c05e4f9f942ad94/image5.png?w=1999&h=1000&q=50 1999w"}}},{"__typename":"ContentfulContentBlockImage","id":"b6aa9bfc-3c11-5f8e-bc01-bc53570e0cd0","contentful_id":"5TGgaBB2RxTULi4HQQxBqo","keepSize":null,"fullWidthMobile":null,"caption":null,"imageLink":null,"childContentfulContentBlockImageLongCaptionTextNode":null,"image":{"file":{"url":"//images.ctfassets.net/o2ll9t4ee8tq/587WQ7ZlXkwNEPW7m4JkrD/569c6ce247e3d12e37c44c594e31081f/image2.png"},"title":"Map with growth in probable cases as share of total","description":"A map of US states shows the growth of probable cases as a share of total cases between August 4, 2020 and March 7, 2021. In five states—Colorado, Delaware, Massachusetts, Michigan and Wyoming—probable cases as a share of total cases slightly decreased. Three states—Connecticut, Maine, and Wisconsin—saw probable cases increase by 1-2x. In four states—Idaho, Kentucky, Ohio and Pennsylvania—probable cases' share increased by between 2-5x. In Alabama, New Jersey, Virginia, and West Virginia, the share increased by 5-10x. And in five states—Arizona, Mississippi, South Carolina, Tennessee, and Washington—the share of probable cases increased by greater than 10.","fluid":{"aspectRatio":1.999,"sizes":"4","src":"//images.ctfassets.net/o2ll9t4ee8tq/587WQ7ZlXkwNEPW7m4JkrD/569c6ce247e3d12e37c44c594e31081f/image2.png?w=2000&q=50","srcSet":"//images.ctfassets.net/o2ll9t4ee8tq/587WQ7ZlXkwNEPW7m4JkrD/569c6ce247e3d12e37c44c594e31081f/image2.png?w=500&h=250&q=50 500w,\n//images.ctfassets.net/o2ll9t4ee8tq/587WQ7ZlXkwNEPW7m4JkrD/569c6ce247e3d12e37c44c594e31081f/image2.png?w=1000&h=500&q=50 1000w,\n//images.ctfassets.net/o2ll9t4ee8tq/587WQ7ZlXkwNEPW7m4JkrD/569c6ce247e3d12e37c44c594e31081f/image2.png?w=1999&h=1000&q=50 1999w"}}},{"__typename":"ContentfulContentBlockFootnote","id":"75b0832d-e00e-5cfc-a566-154810457861","contentful_id":"20UMQrPJuAs7hFGAwvD1fB","footnote":{"footnote":"The boundary between probable cases and antigen positive individuals has been porous since the updated probable case definition, or CSTE-02. There have been a few states that have shared “antigen positives” without clarifying whether they were counting *probable cases*, which will get revised down upon confirmation, or *people testing positive via antigen*, which will not get rounded down."}},{"__typename":"ContentfulContentBlockImage","id":"0bc5932f-41cb-5a66-ad52-b4287654d7ee","contentful_id":"4Mc7UC2CDyAPSeYJN8PVYZ","keepSize":null,"fullWidthMobile":null,"caption":null,"imageLink":null,"childContentfulContentBlockImageLongCaptionTextNode":null,"image":{"file":{"url":"//images.ctfassets.net/o2ll9t4ee8tq/3HwsdyIBha94JEI5QxIlpA/b13ba83b6f17e686d7ae5a7f2880dcd4/image1.jpg"},"title":"New positive antigen tests vs new probable cases","description":"Five graphs plot new antigen positive tests against new probable cases in Arkansas, Connecticut, Maine, Tennessee and Virginia—the five states where the two closely track one another. Four of the five states count tests in units of specimens; Arkansas tracks antigen tests in units of unique people. The graphs also include antigen positives as a percentage of probable cases. In all the states except Connecticut, antigen positive tests as a percentage of probable stays constant just above 100%. In Connecticut, daily antigen positive tests are slightly higher than probable cases—150%, likely reflecting the different in units—but follow the same trendline.","fluid":{"aspectRatio":1.4,"sizes":"4","src":"//images.ctfassets.net/o2ll9t4ee8tq/3HwsdyIBha94JEI5QxIlpA/b13ba83b6f17e686d7ae5a7f2880dcd4/image1.jpg?w=2000&q=50","srcSet":"//images.ctfassets.net/o2ll9t4ee8tq/3HwsdyIBha94JEI5QxIlpA/b13ba83b6f17e686d7ae5a7f2880dcd4/image1.jpg?w=500&h=357&q=50 500w,\n//images.ctfassets.net/o2ll9t4ee8tq/3HwsdyIBha94JEI5QxIlpA/b13ba83b6f17e686d7ae5a7f2880dcd4/image1.jpg?w=1000&h=714&q=50 1000w,\n//images.ctfassets.net/o2ll9t4ee8tq/3HwsdyIBha94JEI5QxIlpA/b13ba83b6f17e686d7ae5a7f2880dcd4/image1.jpg?w=1400&h=1000&q=50 1400w"}}},{"__typename":"ContentfulContentBlockFootnote","id":"75538582-3420-50d2-a0a6-2d80bc947f91","contentful_id":"3W7XubcjnI20L8z1XeWohI","footnote":{"footnote":"Though daily trends differ, South Carolina has a very similar topline number of probable cases and antigen tests, suggesting the difference between trends in antigen positive tests and probable cases could be due to data dumps in one or the other that distorted trends."}},{"__typename":"ContentfulContentBlockImage","id":"b45fa50c-5683-5dd7-9da0-2d20ae7ecd46","contentful_id":"4sN4IldGjQ0LsgSXVFgJhV","keepSize":null,"fullWidthMobile":null,"caption":null,"imageLink":null,"childContentfulContentBlockImageLongCaptionTextNode":null,"image":{"file":{"url":"//images.ctfassets.net/o2ll9t4ee8tq/2J8lJrnZmFQ9GEB8QyaIqS/1308bf7956ab3d39ece3ce24156dac2e/image3.jpg"},"title":"New positive antigen vs probable cases KY/OH/SC/TX","description":"Four graphs plot new antigen positive tests against new probable cases in Kentucky, Ohio, South Carolina, and Texas—the four states where trends differ. In Kentucky and Ohio, daily antigen tests are consistently much lower than daily probable cases. In Texas, daily antigen tests are lower than daily probable cases until the past few weeks of February and the beginning of March. In South Carolina, daily antigen tests are higher than probable cases until mid-February, when probable cases become higher than antigen tests.","fluid":{"aspectRatio":2,"sizes":"4","src":"//images.ctfassets.net/o2ll9t4ee8tq/2J8lJrnZmFQ9GEB8QyaIqS/1308bf7956ab3d39ece3ce24156dac2e/image3.jpg?w=2000&q=50","srcSet":"//images.ctfassets.net/o2ll9t4ee8tq/2J8lJrnZmFQ9GEB8QyaIqS/1308bf7956ab3d39ece3ce24156dac2e/image3.jpg?w=500&h=250&q=50 500w,\n//images.ctfassets.net/o2ll9t4ee8tq/2J8lJrnZmFQ9GEB8QyaIqS/1308bf7956ab3d39ece3ce24156dac2e/image3.jpg?w=1000&h=500&q=50 1000w,\n//images.ctfassets.net/o2ll9t4ee8tq/2J8lJrnZmFQ9GEB8QyaIqS/1308bf7956ab3d39ece3ce24156dac2e/image3.jpg?w=1400&h=700&q=50 1400w"}}}]},"featuredImage":null,"slug":"how-probable-cases-changed-through-the-covid-19-pandemic","lede":{"lede":"When analyzing COVID-19 data, confirmed case counts are obvious to study. But don’t overlook probable cases—and the varying, evolving ways that states have defined them.\n"},"publishDate":"May 20, 2021","chartData":null}},"pageContext":{"id":"865c4e51-3b6d-5b00-8676-bf7d43e11424","contentful_id":"1Q5lsJ7i5vsM3RptAQXY36","slug":"how-probable-cases-changed-through-the-covid-19-pandemic","overrideBlogPage":null,"overrideBlogPath":null,"latestDate":"2021-03-07","sevenDaysAgo":"2021-02-28","fourteenDaysAgo":"2021-02-21","twentyEightDaysAgo":"2021-02-07","ninetyDaysAgo":"2020-12-07"}},"staticQueryHashes":["1039529027","1271460761","2250803104","3649515864","4121435362","775579208"]}